Understanding Your Telehealth Treatment Options for BED
If you’re struggling with binge eating disorder (BED), you may wonder if telehealth offers a viable treatment path—especially when medication might help. With constantly evolving telehealth regulations, many patients have questions: Can I get medications like Topamax (topiramate) or Wellbutrin (bupropion) prescribed online? Do I need an in-person visit first? What about state restrictions or prescription monitoring?
This comprehensive guide answers these questions with the latest 2026 information on telehealth prescribing for non-controlled BED medications, ensuring you understand your access to care.
Free consultations available with select providers only.
Free consultations available with select providers only.
Can I Get BED Medications via Telehealth?
Yes, you can receive prescriptions for non-controlled BED medications via telehealth in all 50 states.
The most important thing to understand is that medications commonly used for BED treatment—such as Topamax (topiramate) and Wellbutrin (bupropion)—are not controlled substances. This critical distinction means they aren’t subject to the strict federal Ryan Haight Act restrictions that limit telehealth prescribing of controlled drugs like stimulants or opioids.
Even as telehealth regulations evolve, access to these non-controlled BED medications remains stable and accessible through virtual care platforms like Klarity Health, where providers can legally prescribe these medications without requiring in-person visits in most cases.
State-by-State Telehealth Prescribing Rules
While federal law allows telehealth prescribing of non-controlled medications nationwide, some states have additional requirements:
States with No In-Person Requirements
Most states, including California, Delaware, New York, Texas, Michigan, and Wisconsin, have no in-person exam requirement for prescribing non-controlled medications via telehealth. As long as the telehealth provider conducts a proper evaluation that meets the standard of care, they can prescribe Topamax or Wellbutrin remotely.
California even clarified in 2025 (AB 1503) that asynchronous telehealth evaluations can qualify as a ‘good faith examination’ for prescribing purposes.
States with Periodic In-Person Requirements
A few states require periodic in-person follow-ups for ongoing telehealth treatment:
Alabama: If you have more than 4 telehealth visits in 12 months for the same condition, you must have an in-person exam within that year
Georgia: Requires an attempt at an annual in-person follow-up for ongoing telemedicine care
New Hampshire: Recently updated laws to allow telehealth prescribing but requires an in-person exam at least every 12 months
Even in these states, the initial evaluation and prescription can typically be done via telehealth, and the follow-up requirement can often be satisfied by any provider in the practice, not necessarily the telehealth doctor.
Who Can Prescribe BED Medications via Telehealth?
Physician Prescribing Authority
Medical doctors (MDs) and doctors of osteopathy (DOs) can prescribe non-controlled BED medications via telehealth in all states, provided they’re licensed in your state.
Nurse Practitioners and Physician Assistants
The landscape for nurse practitioners (NPs) has evolved significantly:
Full Practice Authority States: In approximately 34 states plus DC, nurse practitioners now have full practice authority, meaning they can independently prescribe non-controlled medications without physician oversight. Recent additions to this list include Michigan and Wisconsin (2025).
Collaborative Agreement States: In states like Florida, Texas, Georgia, and Alabama, NPs must work under collaborative agreements with physicians to prescribe. However, they can still prescribe non-controlled medications like Topamax and Wellbutrin for BED.
At Klarity Health, our network includes qualified providers who understand state-specific requirements, ensuring you receive appropriate care regardless of where you live.
The Telehealth Evaluation Process for BED
For a legitimate BED medication evaluation via telehealth, expect:
Initial Assessment
A thorough evaluation of your eating behaviors and patterns
Questions based on DSM-5 criteria (like experiencing episodes of eating an extreme amount within 2 hours, feeling out of control, doing this at least once weekly for 3+ months)
Discussion of your medical history, current medications, and past treatments
Possibly completing standardized questionnaires like the EDE-Q or BES
Treatment Planning
If medication is appropriate, your provider will:
Explain the benefits and risks of medication options
Discuss that medications like Topamax and Wellbutrin are prescribed ‘off-label’ for BED
Create a treatment plan that may include therapy recommendations
Set expectations for follow-up appointments
Follow-Up Care
Expect regular follow-up appointments, typically:
2-week or 1-month check-in after starting medication
Monthly or bi-monthly follow-ups to monitor progress
Adjustment of medications as needed
Discussion of any side effects or concerns
Who Is Not a Good Candidate for Telehealth BED Treatment?
Safety is paramount in telehealth prescribing. You may not be a good candidate for telehealth BED medication if you have:
History of anorexia or bulimia: Bupropion (Wellbutrin) is contraindicated due to increased seizure risk
Seizure disorder: Both medications must be used with extreme caution or avoided
Pregnancy or planning pregnancy: Topiramate can cause birth defects including cleft palate
Severe medical instability: Such as very severe obesity with urgent health complications
Need for controlled medications: If Vyvanse (the only FDA-approved medication for BED, which is a controlled substance) is determined to be the best option, telehealth options may be more limited
Reputable telehealth providers like those at Klarity Health will conduct thorough screenings and refer you to in-person care when appropriate.
Understanding Off-Label Medication Use for BED
Both Topamax and Wellbutrin are prescribed ‘off-label’ for BED, meaning:
Topamax: FDA-approved for seizures and migraines but used for BED based on clinical evidence
Wellbutrin: FDA-approved for depression and smoking cessation but shows effectiveness for some BED patients
Off-label prescribing is legal, common, and supported by clinical research. Your telehealth provider should clearly explain this and document your informed consent. At Klarity Health, our providers ensure you understand the rationale behind medication recommendations and discuss all treatment options.
Prescription Details and Follow-Up Requirements
Typical Prescription Process
Initial prescriptions are usually for 30-90 days
Providers can authorize refills (typically up to 6-11 months, depending on state limits)
Prescriptions are sent electronically to your local pharmacy
Unlike controlled substances, these medications don’t require monthly visits for refills
State-Specific Follow-Up Requirements
Some states require periodic follow-ups:
Alabama, Georgia, New Hampshire: Annual in-person follow-up required
Most other states: No specific in-person requirement, but follow-ups based on clinical need
Safety and Quality in Telehealth BED Treatment
Legitimate telehealth services implement strict protocols to ensure quality care:
Identity and Location Verification
Expect providers to verify your identity and location—this ensures they’re licensed in your state and prevents fraud.
Thorough Medical History
A proper telehealth evaluation should be comprehensive—typically 30+ minutes for an initial BED consultation. Brief questionnaire-only evaluations with immediate prescriptions are red flags.
Prescription Monitoring Program Checks
Even though not legally required for non-controlled medications in most states, many providers check state prescription monitoring databases as a safety precaution.
Pharmacy Coordination
Prescriptions should be sent electronically to a legitimate pharmacy of your choice—not shipped directly from the provider.
Recent Regulatory Developments (2025-2026)
The telehealth regulatory landscape continues to evolve:
The DEA extended pandemic telehealth flexibilities for controlled substances through December 31, 2026
Several states modified their telehealth laws in 2025, generally expanding access
More states granted full practice authority to nurse practitioners